1. Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancer cases excludes additional high-impact susceptibility genes. (November 2022) Authors: Loveday, C.; Garrett, A.; Law, P.; Hanks, S.; Poyastro-Pearson, E.; Eccles, D.; Evans, G.; Snape, K.; Hanson, H.; Houlston, R.; Turnbull, C. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Succinate dehydrogenase mutations: paraganglioma imaging and at-risk population screening. Issue 3 (March 2019) Authors: Cavenagh, T.; Patel, J.; Nakhla, N.; Elstob, A.; Ingram, M.; Barber, B.; Snape, K.; Bano, G.; Vlahos, I. Journal: Clinical radiology Issue: Volume 74:Issue 3(2019) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗